Core E core Director Frankel, Paul Principal investigator: Raubitschek, AndrewDESCRIPTION:The Biostatistics Core serves as a centralized resource to the investigators of the Antibody TargetedRadiation and Immunotherapy for the Treatment of Solid Tumors Program Project Grant (PPG), providingDiostatistical expertise and clinical research management resources to all projects. The Biostatistics Coreincludes two Senior Biostatisticians (one is the Core Director), 1 Staff Biostatistician, a Quality AssuranceClinical Research Associate, and a Clinical Research Associate. The Biostatistics Core provides study design,sample size projections, safety monitoring, case form development, data collection, data quality assurance,statistical programming, summary and analysis of study results, and collaboration in writing abstracts andpeer-review publications. Statistical analyses are performed using SAS, S-PLUS, R software packages, andspecialty software. The Biostatistics Core ensures that the proposed research hypothesis will be measured,tested, and interpreted, independent of whether the data comes from basic science, translational ormmunologic studies, imaging, or clinical trials. The Biostatistics Core will also continue to providenfrastructure for the management and integration of both existing and newly collected data throughconsistent and compatible data handling, which is particularly important given the large amount of datacollected and processed as part of the Imaging Response Assessment Team (IRAT), the IRAT workstationthat will employed for this PPG, and the important cross study analysis that will be conducted. The Core willcontinue to have an integral role in the scientific development, execution and analysis of all projects in thePPG, including clinical trials. Core investigators have extensive experience in quantitative methods forbiomedical applications, including clinical, basic and translational science studies. The Core is committed tocontinue its leadership role in the scientific integrity of the PPG investigations, to participating in regularproject and program meetings, and to providing rigorous and innovative input on all quantitative mattersarising in the projects. Their contribution to each project promotes interdisciplinary interactions andinnovative hypotheses for exploration. The Biostatistics Core has been involved in study design for eachspecific aims of the current proposal, and will continue to be a critical component to successful conduct of thePPG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA043904-16A1
Application #
7303278
Study Section
Special Emphasis Panel (ZCA1-RPRB-J (M1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-08-13
Budget End
2008-06-30
Support Year
16
Fiscal Year
2007
Total Cost
$183,198
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Sta Maria, Naomi S; Barnes, Samuel R; Weist, Michael R et al. (2015) Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells. PLoS One 10:e0142767
Kwok, Cheuk S; Frankel, Paul H; Lopatin, George et al. (2014) Using a single parameter to describe time-activity curves. Cancer Biother Radiopharm 29:83-6
Yazaki, Paul J; Lee, Brian; Channappa, Divya et al. (2013) A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance. Protein Eng Des Sel 26:187-93
Ng, Thomas S C; Wert, David; Sohi, Hargun et al. (2013) Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101. Clin Cancer Res 19:2518-27
Specks, Ulrich; Ikle, David; Stone, John H (2013) Induction regimens for ANCA-Associated Vasculitis. N Engl J Med 369:1865-6
Fonge, Humphrey; Leyton, Jeffrey V (2013) Positron emission tomographic imaging of iodine 124 anti-prostate stem cell antigen-engineered antibody fragments in LAPC-9 tumor-bearing severe combined immunodeficiency mice. Mol Imaging 12:191-202
Povoski, Stephen P; Davis, Paul D; Colcher, David et al. (2013) Single molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics. Expert Rev Mol Diagn 13:315-9
Barat, Bhaswati; Kenanova, Vania E; Olafsen, Tove et al. (2011) Evaluation of two internalizing carcinoembryonic antigen reporter genes for molecular imaging. Mol Imaging Biol 13:526-535
Somlo, George; Spielberger, Ricardo; Frankel, Paul et al. (2011) Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma. Clin Cancer Res 17:174-82
Li, Lin; Turatti, Fabio; Crow, Desiree et al. (2010) Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET. J Nucl Med 51:1139-46

Showing the most recent 10 out of 112 publications